The HawkOne, a directional atherectomy system developed to address extremely calcified lesions in lower extremities' blood vessels, is being launched by Medtronic. The device was obtained by the company in its recent acquisition of Covidien.
InspireMD hopes to secure $13.8 million through a public offering of warrants and company stock. The Boston-based firm will use the money to introduce its CGuard MicroNet carotid stent and other products.
Fire1, an Irish startup focused on novel therapeutic devices, has closed its Series A funding round that includes Covidien. Fire1 is adding Stacy Enxing Seng, president of Covidien's vascular therapies business, to its board, indicating that the startup could be involved in the vascular market.
The FDA has given Olympus Medical 510(k) clearance to market its Articulating HD 3D system, which is used to aid surgeons in performing laparoscopic procedures more efficiently and accurately. The device adds another 3D video-imaging option to the firm's Evis Exera III technology.
Blue Medical Devices, a vascular disease therapy device maker in the Netherlands, has appointed Noël Coopmans to serve as its CEO. Coopmans replaces Ronald Horvers, who will remain with the company as chief financial officer and chief technology officer.